title: The effect of ondansetron and intrathecal diamorphine on length of stay after caesarean section: an impact audit cycle.
authors.forename: R K
authors.initials: RK
authors.lastname: Puttaswamy
authors.forename: S
authors.initials: S
authors.lastname: Valap
authors.forename: R
authors.initials: R
authors.lastname: Pierson
authors.forename: B
authors.initials: B
authors.lastname: Das
authors.forename: M
authors.initials: M
authors.lastname: Hodges
authors.forename: R
authors.initials: R
authors.lastname: Hodgson
authors.forename: S
authors.initials: S
authors.lastname: Chaudhari
authors.forename: S
authors.initials: S
authors.lastname: Botros
authors.forename: P
authors.initials: P
authors.lastname: Moore
mesh_terms: D000328:Adult; D000701:Analgesics, Opioid / Q000008:administration & dosage / Q000627:therapeutic use*; D000773:Anesthesia, Obstetrical; D000932:Antiemetics / Q000008:administration & dosage / Q000627:therapeutic use*; D002585:Cesarean Section / Q000706:statistics & numerical data*; D005260:Female; D003932:Heroin / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007278:Injections, Spinal; D007902:Length of Stay; D017294:Ondansetron / Q000008:administration & dosage / Q000627:therapeutic use*; D011183:Postoperative Complications / Q000517:prevention & control; D020250:Postoperative Nausea and Vomiting / Q000517:prevention & control; D011247:Pregnancy; D011537:Pruritus / Q000517:prevention & control
chemical_list: D000701:Analgesics, Opioid; D000932:Antiemetics; D017294:Ondansetron; D003932:Heroin